首页> 外文期刊>Endocrine. >Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas
【24h】

Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas

机译:缺点:对于垂体腺瘤,内镜鼻内经蝶窦垂体手术并不优于经镜经鼻蝶窦手术

获取原文
获取原文并翻译 | 示例
       

摘要

The introduction of the endoscope to transsphenoidal pituitary surgery is not new and it has been abandoned in the past. Now, after some technological advances has been proposed again as an advancement in this field. However, there is still a debate on this topic and some authors consider endoscopic surgery a form of developing surgery in an evolution step. The use of the endoscope to visualize the sella has been suggested to offer a better visualization as well as an improved range of motion compared to the operating microscope. However, the real advantage in terms of efficacy and safety is still matter of debate. The conversion to microsurgery has been reported in a significant number of cases, particularly in recurrences, where the difficulties of reoperation require more skill. There is evidence in recent studies that the endonasal and bleeding complications are significantly higher in endoscopic approaches than in microscopic ones. In particular, patient discomfort, smell, and taste impairment are higher with the endoscopic method compared with microscopic approaches. At present pure endoscopic transsphenoidal surgery is not a cost effective technology. In fact, the operative time is longer than in microscopic approaches and the number of surgeons required for the procedure is usually double compared to microscopic approaches. This paper will outline on the basis of the data available in literature the reasons why, at present, the pure endoscopic endonasal transsphenoidal surgery should not be yet considered the standard technique for transsphenoidal surgery in patients with pituitary adenomas.
机译:内窥镜在经蝶窦垂体手术中的应用并不是什么新鲜事,在过去已被放弃。现在,在此领域的进步之后,又提出了一些技术进步。然而,关于这一主题仍存在争议,一些作者认为内窥镜手术是在进化步骤中发展外科手术的一种形式。与手术显微镜相比,已建议使用内窥镜对蝶鞍进行可视化,以提供更好的可视化以及更好的运动范围。但是,关于功效和安全性的真正优势仍存在争议。据报道,在许多情况下,尤其是在复发中,显微手术已转变为显微外科手术,其中再手术的困难需要更多的技能。在最近的研究中有证据表明,内窥镜检查方法的鼻内和出血并发症明显高于镜下检查方法。特别地,与显微方法相比,内窥镜方法患者的不适,气味和味觉损害更高。目前,单纯的内镜经蝶窦手术并不是一种经济有效的技术。实际上,手术时间比显微方法要长,而且手术所需的外科医生人数通常比显微方法要多一倍。本文将基于文献中的数据概述为什么目前尚不将单纯的内窥镜鼻内经蝶窦手术作为垂体腺瘤患者经蝶窦手术的标准技术的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号